11/06/2021
Hot Topics of the Day are picked by experts to capture the latest information and publications on public health genomics and precision health for various diseases and health topics. Sources include published scientific literature, reviews, blogs and popular press articles.
Sign up MyPHGKB to receive the daily hot topic email alert.
Archived Hot Topics of the Day By Date
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
KR Woodworth et al, MMWR, November 5, 2021
The United States COVID-19 Forecast Hub dataset
EY Cramer et al, MEDRXIV, November 4,202
Evaluation of a Machine Learning Approach Utilizing Wearable Data for Prediction of SARS-CoV-2 Infection in Healthcare Workers
RP Hirten et al, MEDRXIV, November 5, 2021
Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
ZL Lyski et al, MEDRXIV, November 5, 2021
Machine Learning in the analysis of lethality and evolution of infection by the SARS-CoV-2 virus (COVID-19) in workers of the Mexico City Metro
EIG Islas et al, MEDRXIV, November 5, 2021
The Role of CRP, Interleukin-6 and Their Derived Immune-Inflammatory Indices in Early Prediction of Severity and Mortality of COVID-19 Patients
SI Taha et al, MEDRXIV, November 5, 2021
Comparison of Antibody Levels in Response to SARS-CoV-2 Infection and Vaccination Type in a Midwestern Cohort
L Remy et al, MEDRXIV, November 5, 2021
Pediatric COVID-19 Vaccines- What Parents, Practitioners, and Policy Makers Need to Know
WJ Moss et al, JAMA, November 5, 2021
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
JAMA Network Open, November 5,2021
Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
C D'Avella et al, JAMA Network Open, November 5, 2021
The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
KKH Bao et al, JAMA Network Open, November 5, 2021
The language of genetics
Nature Genetics editorial, November 5, 2021
Disclaimer: Articles listed in Hot Topics of the Day are selected by Public Health Genomics Branch to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: